Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study

Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study

ObjectiveWe aimed to explore the predictive value of stimulated thyroglobulin (sTg) and pre-ablation antithyroglobulin (pa-TgAb) products for the effect of radioiodine therapy (RAIT) on TgAb-positive differentiated thyroid cancer (DTC) patients.MethodsIn this study, we enrolled 265 patients with TgA...

Full description

Bibliographic Details
Main Authors: Na Han, Chenghui Lu, Jiao Li, Congcong Wang, Zilong Zhao, Yingying Zhang, Xinfeng Liu, Zengmei Si, Guoqiang Wang, Zenghua Wang, Fengqi Li, Xufu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Endocrinology
Subjects:
differentiated thyroid cancer
serum antithyroglobulin antibody
radioiodine therapy
response to therapy
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1222470/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1222470/full

Similar Items